Neutralising antibodies formed in more than 90% of the participants by
day 29 and in 100% of the participants aged 18-55 years on day 57.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/jjs-one-dose-vax-elicits-strong-immune-response/articleshow/80273809.cms
No comments:
Post a Comment